Is THRM a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Gentherm Incorporated (THRM) rests on Modine Performance Technologies integration: The October 2026 combination roughly doubles revenue and shifts the mix toward commercial vehicle, off-highway and power generation cooling. The bear case rests on integration is the largest new risk: combining two engineering and manufacturing organizations across many countries can disrupt customers and delay synergies. Analysts covering it publish targets from $34.00 to $59.00 against a $31.30 price, so even the professionals disagree by 52% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Gentherm Incorporated, based in Novi, Michigan, designs and makes thermal and pneumatic comfort products. Its core business is automotive climate and comfort: Climate Control Seats (heated, ventilated and cooled seats) generated about $218 million of the company's record ~$416 million of product revenue in Q2 2026, alongside steering wheel heaters, battery thermal products, lumbar and massage systems, and a small medical patient temperature management unit (~$11 million a quarter). On October 1, 2026 it completed a Reverse Morris Trust combination with Modine Manufacturing's Performance Technologies business (about $1.1 billion of revenue), which adds engine and battery cooling, radiators and coolers for commercial vehicles, off-highway equipment and power generation. Former Modine holders own roughly 43.6% of the combined company. The investment picture is now about scale and mix. Standalone, Gentherm guided 2026 product revenue to $1.55 to $1.65 billion and adjusted EBITDA to $185 to $200 million, raised in July after it outgrew light vehicle production by about 14 points and booked ~$690 million of new automotive awards in one quarter. Management's deal case pointed to ~$2.6 billion of pro forma revenue, ~$322 million of adjusted EBITDA including ~$25 million of cost synergies, and net leverage near 1.0x. At roughly $30 a share and about 54 to 55 million shares after closing, the market value sits near $1.6 billion, so the stock is priced at a low multiple of combined EBITDA. Whether that discount closes depends on integration, synergy delivery, and the auto and heavy-truck cycles. Gentherm began in 1991 in California as Amerigon, moved its base to Michigan in 2005, bought a majority stake in German seat-heater maker W.E.T. in 2011 and took the Gentherm name in 2012. It moved its headquarters from Northville to a new building in Novi, Michigan in early 2025. Full-year 2025 product revenue was about $1.50 billion, up 2.9%, split among Climate Control Seats ($793 million), Lumbar and Massage Comfort Solutions ($212 million, up 18.8%), Climate Control Interiors such as steering wheel heat ($198 million), Valve Systems ($97 million) and Medical ($50 million). GAAP net income fell to $18.3 million from $64.9 million in 2024. Before the merger the company had about 14,200 employees, the largest group (about 5,500) in Mexico. Bill Presley, formerly vice chairman and COO of Aptiv, has been CEO since January 1, 2025.

The bull case: what would have to be true for $59.00

The most optimistic published target on THRM is $59.00, +88.5% from the $31.30 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Modine Performance Technologies integration

The October 2026 combination roughly doubles revenue and shifts the mix toward commercial vehicle, off-highway and power generation cooling. Management targets about $25 million of annual cost synergies, and delivering them on schedule is the clearest near-term test of the deal. The January deal presentation framed those savings as a path to mid-teens adjusted EBITDA margins, alongside cross-selling Gentherm's valve technology into Modine's thermal systems and using the Performance Technologies footprint to enter new markets such as India. A few terms shifted before closing: Modine's cash distribution came in at about $156 million against $210 million first announced, the ownership split moved to about 56/44 from roughly 60/40, and Katrin Schatz is serving as interim president of the division rather than Jeremy Patten, who had been slated to stay on.

2. Seat comfort content growth

Gentherm has been growing faster than global light vehicle output by adding heated, ventilated and massage content per vehicle, particularly with Asian automakers. The ~$690 million of automotive awards booked in Q2 2026 supports revenue visibility into future model years.

3. Margin expansion and cash generation

Adjusted EBITDA margin was about 11.7% in Q2 2026, and the company raised its full-year adjusted free cash flow range to $85 to $100 million. Footprint moves to lower-cost regions and the deal's synergies are the levers behind the targeted move toward a ~13% combined margin.

4. Capital returns

The board authorized a new $400 million buyback in 2026 and declared a special cash dividend (about $2.07 per share, payable October 7, 2026) tied to the Modine closing. With pro forma leverage near 1.0x, the balance sheet leaves room for continued repurchases.

5. Power generation and data center cooling

Performance Technologies, which traces its history back more than 100 years, makes charge-air coolers, generator-set cooling modules, vehicle cooling modules, liquid-cooled products, battery thermal management and electric fan modules. Gentherm's deal materials put about one-third of pro forma revenue in power generation, commercial vehicle and heavy-duty equipment, and projected 20%+ annual market growth in power generation through 2029, citing data center backup power and grid reliability. The near-term record is mixed: in Modine's fiscal fourth quarter ended March 2026, segment sales were flat at $294 million as stationary power sales fell, and adjusted EBITDA dropped 15% to $37.4 million.

6. Home, office and medical adjacencies

Gentherm has been taking its seat comfort technology outside the car. In Q2 2026 two North American furniture brands selected it to supply climate and comfort products, its fourth straight quarter of new home and office customers. In medical, it bought Innovative Medical Equipment, maker of the ThermaZone thermal therapy device, adding to the Blanketrol and Astotherm patient temperature lines. These businesses are small today, with Medical at about $50 million of 2025 revenue, but they are the stated route to growth that does not depend on vehicle builds.

The bear case: what would have to be true for $34.00

The most pessimistic published target is $34.00, +8.6% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Gentherm Incorporated is worth if the risks below bite instead of the drivers above.

Integration is the largest new risk: combining two engineering and manufacturing organizations across many countries can disrupt customers and delay synergies. The legacy business is tied to light vehicle production, which management assumes will fall at a low single digit rate in 2026, and the acquired business adds exposure to the cyclical commercial truck and off-highway markets. Tariffs and trade policy affect a footprint spread across Mexico, Europe and Asia, and gross margin slipped to about 23.2% in Q2 2026 from 23.9% a year earlier. Customer concentration among large automakers and competition from bigger seat and thermal suppliers can pressure pricing. Customer concentration is high: Lear and Adient, which build complete seats, bought $234 million and $164 million of product in 2025 (16% and 11% of product revenue), and products ending up in General Motors and Volkswagen vehicles each represented 12%. About 36% of the workforce belongs to unions or works councils, and roughly 1,300 employees were based in Ukraine at the end of 2025. Medical carries goodwill whose estimated fair value exceeded carrying value by only about 25% at year-end 2025, a margin the company flagged as at risk in future impairment tests. Cash generation was soft in Q2 2026, with operating cash flow of $2.3 million versus $31.7 million a year earlier because of restructuring and merger costs, and Performance Technologies' gross margin fell 390 basis points to 16.5% in Modine's March quarter on material costs and tariffs.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding THRM already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on THRM

8 analysts cover THRM, with an average target of $48.00 (+53.4% against $31.30) and a split of 6 buy, 3 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the THRM forecast and price target page.

How is THRM valued? (as of October 2026)

Price
$31.30
Market cap
$962.13M
P/E (TTM)
39.12
Forward P/E
9.66
Price / book
1.33
Beta
1.34
52-week range
$27.00 to $48.35

Snapshot for THRM as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (TTM, standalone): ~$1.55B
  • 2026 revenue guidance (standalone): ~$1.55B to $1.65B
  • Pro forma combined revenue: ~$2.6B
  • Q2 2026 adjusted EPS: ~$0.75
  • Share price: ~$30
  • Market cap (post-closing): ~$1.6B

Standalone figures exclude Modine Performance Technologies, which closed on October 1, 2026, so trailing ratios will shift sharply once combined results are reported. Against management's ~$322 million pro forma adjusted EBITDA (including synergies), the market value implies a low single digit to mid single digit EBITDA multiple before debt, a discount that reflects auto and truck cyclicality and integration uncertainty. On the balance sheet, standalone Gentherm ended June 2026 with $273 million of debt, $213 million of cash, net leverage of about 0.3x and $502 million of liquidity. At closing, the spun-off business borrowed $250 million under a delayed-draw term loan administered by Bank of America, priced at SOFR plus 1.125% to 2.0% depending on leverage, which now sits inside the combined company, and the special dividend paid out about $63.5 million. Share count rose to roughly 54.4 million after 23.7 million new shares went to Modine holders.

How do you decide if THRM is a buy?

Rather than asking whether THRM is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold THRM indirectly through an index or sector ETF before adding more.

What would change your mind on THRM

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Modine Performance Technologies integration stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: integration is the largest new risk: combining two engineering and manufacturing organizations across many countries can disrupt customers and delay synergies fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the THRM stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about THRM against your real portfolio and see your actual exposure before deciding.

Investing in Gentherm Incorporated with AI

Connect the broker you already use and ask Walnut's AI how THRM fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is THRM a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Modine Performance Technologies integration, with revenue (ttm, standalone) at ~$1.55B. The bear case rests on integration is the largest new risk: combining two engineering and manufacturing organizations across many countries can disrupt customers and delay synergies. Analysts covering it are spread from $34.00 to $59.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell THRM?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Integration is the largest new risk: combining two engineering and manufacturing organizations across many countries can disrupt customers and delay synergies. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $34.00, +8.6% from the $31.30 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for THRM?

+

Modine Performance Technologies integration. The October 2026 combination roughly doubles revenue and shifts the mix toward commercial vehicle, off-highway and power generation cooling. The most optimistic analyst target on THRM is $59.00, +88.5% from the $31.30 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for THRM?

+

Integration is the largest new risk: combining two engineering and manufacturing organizations across many countries can disrupt customers and delay synergies. The legacy business is tied to light vehicle production, which management assumes will fall at a low single digit rate in 2026, and the acquired business adds exposure to the cyclical commercial truck and off-highway markets. Tariffs and trade policy affect a footprint spread across Mexico, Europe and Asia, and gross margin slipped to about 23.2% in Q2 2026 from 23.9% a year earlier. Customer concentration among large automakers and competition from bigger seat and thermal suppliers can pressure pricing. Customer concentration is high: Lear and Adient, which build complete seats, bought $234 million and $164 million of product in 2025 (16% and 11% of product revenue), and products ending up in General Motors and Volkswagen vehicles each represented 12%. About 36% of the workforce belongs to unions or works councils, and roughly 1,300 employees were based in Ukraine at the end of 2025. Medical carries goodwill whose estimated fair value exceeded carrying value by only about 25% at year-end 2025, a margin the company flagged as at risk in future impairment tests. Cash generation was soft in Q2 2026, with operating cash flow of $2.3 million versus $31.7 million a year earlier because of restructuring and merger costs, and Performance Technologies' gross margin fell 390 basis points to 16.5% in Modine's March quarter on material costs and tariffs. The most pessimistic published target is $34.00, +8.6% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Gentherm Incorporated do?

+

Maker of heated and ventilated car seats and thermal products that added Modine's Performance Technologies cooling business in October 2026.

What would have to change for THRM to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Modine Performance Technologies integration) stalling in the reported numbers rather than in the narrative, the risk above (integration is the largest new risk: combining two engineering and manufacturing organizations across many countries can disrupt customers and delay synergies) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Gentherm do?

+

Gentherm designs and manufactures thermal management and comfort products, best known for heated, ventilated and cooled car seats sold under the Climate Control Seat name. It also makes steering wheel heaters, battery thermal products, massage and lumbar systems, medical patient warming products, and, since October 2026, Modine's former commercial vehicle and industrial cooling products.

What happened with Gentherm and Modine?

+

On October 1, 2026 Gentherm completed a Reverse Morris Trust combination with Modine Manufacturing's Performance Technologies business, first announced on January 29, 2026. Modine shareholders received about 0.446 Gentherm shares per Modine share and own about 43.6% of the combined company, with Gentherm's prior holders owning about 56.4%.

How big is Gentherm now?

+

Standalone Gentherm guided 2026 product revenue to about $1.55 to $1.65 billion. Adding Performance Technologies, which had about $1.1 billion of trailing revenue, brings pro forma revenue to roughly $2.6 billion as of October 2026, with a market value near $1.6 billion at about $30 a share.

Walnut is informational, not investment advice, and gives no verdict on THRM. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

The case for and against similar stocks